This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) shed 2.08% to $285.50 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index  rising 0.46% to 6,909.79 and the Dow Jones Industrial Average  rising 0.16% to 48,442.41.
Insulet Corp. closed 19.55% short of its 52-week high of $354.88, which the company achieved on November 20th.
The stock underperformed when compared to some of its competitors Tuesday, as Eli Lilly &amp; Co. (LLY) fell 0.45% to $1,071.64, DexCom Inc. (DXCM) fell 0.85% to $66.86, and Johnson &amp; Johnson (JNJ) fell 0.74% to $205.78.
Trading volume (573,251) remained 105,168 below its 50-day average volume of 678,419.
Data source: Dow Jones Market Data, FactSet. Data compiled December 23, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-23-25 1708ET

PODD

<p>Insulet Corp.'s stock fell 2.08% to $285.50 on Tuesday, underperforming compared to competitors like Eli Lilly, DexCom, and Johnson & Johnson, despite a positive trading session for the market. The stock is 19.55% below its 52-week high. Trading volume was below the 50-day average.</p>

Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors